title: Verification of measles elimination in Australia: Application of World Health Organization regional guidelines.
abstract: The World Health Organization (WHO) Western Pacific Region (WPR) Guidelines on verification of measles elimination were established in 2012. This article outlines Australia's approach to addressing the guideline's five lines of evidence, which led to formal verification of elimination by the WHO Regional Verification Commission (RVC) in March 2014.
  
  
  
  The criteria were addressed using national measles notifications, data from selected laboratories, the national childhood immunization register, and three national serosurveys (1998/1999, 2002, 2007).
  
  
  
  Australia met or exceeded all indicator targets with either national or sentinel data. Laboratory and epidemiological surveillance were of high quality, with 85% of cases documented as imported/import-related (target 80%); coverage with the first dose of measles vaccine was close to 94% in 2008-2012 and second dose coverage increased to 91% in 2012 (target >95%). There is ongoing commitment by the Australian Government to increase immunization coverage, and the absence of sustained transmission of any single measles genotype was demonstrated.
  
  
  
  This is the first documentation of the successful application of the WPR RVC guidelines. The indicators afford some flexibility but appear to provide appropriate rigor to judge achievement of measles elimination. Our experience could assist other countries seeking to verify their elimination status.
authors.affiliation: School of Public Health and Community Medicine, UNSW Medicine, Sydney, Australia; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital Network, Westmead, New South Wales, Australia. Electronic address: hgidding@unsw.edu.
authors.forename: H F
authors.initials: HF
authors.lastname: Gidding
authors.affiliation: Office of Health Protection, Department of Health, Canberra, Australia.
authors.forename: N V
authors.initials: NV
authors.lastname: Martin
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia.
authors.forename: V
authors.initials: V
authors.lastname: Stambos
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia.
authors.forename: T
authors.initials: T
authors.lastname: Tran
authors.affiliation: National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital Network, Westmead, New South Wales, Australia; The University of Sydney, New South Wales, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Dey
authors.affiliation: Communicable Disease Control Directorate, Department of Health, Perth, Western Australia, Australia.
authors.forename: G K
authors.initials: GK
authors.lastname: Dowse
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; Australian National University, Canberra, Australia.
authors.forename: H A
authors.initials: HA
authors.lastname: Kelly
authors.affiliation: School of Medicine and Public Health, University of Newcastle, New South Wales, Australia.
authors.forename: D N
authors.initials: DN
authors.lastname: Durrheim
authors.affiliation: Queensland Children's Medical Research Institute, Children's Hospital and Health Service, Queensland Health, Australia; UQ Child Health Research Centre, The University of Queensland, Australia; Communicable Diseases Branch, Prevention Division, Queensland Health, Australia.
authors.forename: S B
authors.initials: SB
authors.lastname: Lambert
mesh_terms: D000293:Adolescent; D000328:Adult; D001315:Australia; D002648:Child; D002675:Child, Preschool; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data*; D006801:Humans; D007223:Infant; D008297:Male; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine / Q000627:therapeutic use*; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D014944:World Health Organization; D055815:Young Adult
chemical_list: D008458:Measles Vaccine
keywords: Disease elimination; Measles; Surveillance
references.citation: N S W Public Health Bull. 2003 Apr-May;14(4-5):90-3
references.pmid: 12806408
references.citation: Open Forum Infect Dis. 2015 Apr 15;2(2):ofv048
references.pmid: 26110163
references.citation: Int J Infect Dis. 2002 Dec;6(4):277-82
references.pmid: 12718821
references.citation: Aust Fam Physician. 1999 Jan;28(1):55-60
references.pmid: 9988916
references.citation: Bull World Health Organ. 2009 Jan;87(1):64-71
references.pmid: 19197406
references.citation: J Infect Dis. 2011 Jul;204 Suppl 1:S1-569
references.pmid: 21774106
references.citation: Bull World Health Organ. 2001;79(9):882-8
references.pmid: 11584738
references.citation: JAMA Pediatr. 2014 Feb;168(2):148-55
references.pmid: 24311021
references.citation: Am J Epidemiol. 2000 Jun 1;151(11):1039-48; discussion 1049-52
references.pmid: 10873127
references.citation: Vaccine. 2007 May 4;25(18):3574-80
references.pmid: 17300858
references.citation: Western Pac Surveill Response J. 2015 Jan 30;5(1):14-20
references.pmid: 25635228
references.citation: Wkly Epidemiol Rec. 2013 Mar 1;88(9):89-99
references.pmid: 23540051
references.citation: Bull World Health Organ. 2014 Mar 1;92(3):171-7
references.pmid: 24700976
references.citation: MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1246-51
references.pmid: 26562349
references.citation: Vaccine. 2002 Aug 19;20(25-26):3130-6
references.pmid: 12163264
references.citation: Lancet. 2012 Jun 9;379(9832):2173-8
references.pmid: 22534001